论文部分内容阅读
消化道肿瘤腹腔内复发和肝转移 ,是晚期消化道肿瘤治疗的难题 ,为探讨切实有效的辅助治疗措施。对 40例消化道肿瘤行卡铂、5 Fu、腹腔内灌注 ,与 40例单用静脉化疗相比较。腹腔化疗组 5a复发率 (32 5 % )明显低于静脉化疗组(6 0 % ) ;5a生存率 (72 5 % )明显高于静脉化疗组 (42 5 % )。腹腔化疗组全身毒副反应明显低于静脉化疗组。腹腔热灌注化疗对消化道肿瘤腹腔内复发及肝转移的预防和治疗颇有意义
The intra-abdominal recurrence and liver metastases of digestive tract tumors are difficult problems for the treatment of advanced digestive tract tumors, in order to explore effective and effective supplementary treatment measures. Carboplatin, 5 Fu, and intraperitoneal perfusion were performed on 40 cases of digestive tract tumors, compared with 40 cases of intravenous chemotherapy alone. The recurrence rate of 5a in the intraperitoneal chemotherapy group (32.5%) was significantly lower than that in the intravenous chemotherapy group (60%); the 5-year survival rate (72.5%) was significantly higher than that in the intravenous chemotherapy group (42.5%). The systemic toxicity of the intraperitoneal chemotherapy group was significantly lower than that of the intravenous chemotherapy group. Peritoneal hyperthermic perfusion chemotherapy is significant for the prevention and treatment of intra-abdominal recurrence and liver metastasis of digestive tract tumors